Stay connected with Necrobiosis Lipoidica study info

Publications

Filter By:

Clear Filters

YH12852, a Potent and Selective Receptor Agonist of 5-hydroxytryptamine, Increased Gastrointestinal Motility in Healthy Volunteers and Patients With Functional Constipation

PCS12852

November 17, 2020

Lee HA, Moon SJ, Yoo H, Kim MK, Jang SB, Lee S, Kim S, Lee H.

View Publication

Necrobiosis Lipoidica

Necrobiosis Lipoidica (NL)

November 1, 2020

Wanat K, Rosenbach M.

Gastroparesis: Etiology, clinical manifestations, and diagnosis.

Gastroparesis

September 1, 2020

Camilleri, M.

View Publication

Epidemiology and Diagnosis of Gastroparesis in the United States: A Population-based Study

Gastroparesis

January 1, 2020

Syed AR, Wolfe MM, Calles-Escandon J.

View Publication

Diabetic Gastroparesis: Principles and Current Trends in Management

Gastroparesis

July 9, 2018

Krishnasamy S, Abell TL.

View Publication

Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review

PCS6422

March 30, 2016

Cadoo KA, Gajria D, Suh E, Patil S, Theodoulou M, Norton L, Hudis CA, Traina TA.

View Publication

Cofactors and comorbidities of necrobiosis lipoidica: analysis of the German DRG data from 2012

Necrobiosis Lipoidica (NL)

March 1, 2016

Jockenhöfer F, Kröger K, Klode J, Renner R, Erfurt-Berge C, Dissemond J.

View Publication

A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney Disease.

PCS499

February 11, 2016

Sabounjian L, Graham P, Wu L, Braman V, Cheng C, Liu J, Shipley J, Neutel J, Dao M.

View Publication

Updated results of 100 patients on clinical features and therapeutic options in necrobiosis lipoidica in a retrospective multicentre study

Necrobiosis Lipoidica (NL)

December 25, 2015

Erfurt-Berge C, Dissemond J, Schwede K, Seitz AT, Al Ghazal P, Wollina U, Renner R

View Publication